Study directory

Schizophrenia studies

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
4306studies shown
Showing 2,701-2,712 of 4,306
Drug study icon
Active Not RecruitingNCT06105151

Safety study of Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules in Schizophrenia

This study is active but not recruiting in China. It is testing Safety, Tolerability, Pharmacokinetics and Food Effects of VV119 Capsules for Schizophrenia.

In Beijing
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugA study involving a medication or substance.From 18 Years to 60 Years
Countries
China
Sponsor
Vigonvita Life Sciences
Condition
Schizophrenia
Drug study icon
CompletedNCT00080327

Three Doses of Aripiprazole in people with Acute Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Wallingford
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Condition
Schizophrenia
Other study type icon
CompletedNCT02248987

Study on Abnormal Dopamine Synthesis and Connectivity According to the Antipsychotic Treatment Response in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

In Seoul
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaObservationalA study where researchers collect information without assigning a treatment.From 20 Years to 55 Years
Countries
South Korea
Sponsor
Seoul National University Hospital
Condition
Schizophrenia
Behavioral study icon
CompletedNCT01433094

Study on Psychoeducation Enhancing Results of Adherence in Schizophrenia

This summary needs review. Please check the official study record and contact the research team for details.

Multiple locations, including Urbino
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaBehavioralFrom 18 Years to 55 Years
Countries
Italy
Sponsor
University of Cagliari
Condition
Schizophrenia
Drug study icon
CompletedNCT02876900

HP3070 for schizophrenia

This study is completed in the United States. It is testing HP3070 for schizophrenia.

In Jersey City
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugOver 18 Years
Countries
United States
Sponsor
Noven Pharmaceuticals, Inc.
Condition
Schizophrenia
Drug study icon
CompletedNCT00921804

Safety study of Efficacy, Safety, and Tolerability of AZD8529 in schizophrenia

This study is completed in the United States. It is testing Efficacy, Safety, and Tolerability of AZD8529 for schizophrenia.

Multiple locations, including Garden Grove
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 65 Years
Countries
United States
Sponsor
AstraZeneca
Condition
Schizophrenia
Drug study icon
CompletedNCT02037074

Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen for schizophrenia

This study is completed in the United States. It is testing Safety, Tolerability, Pharmacokinetic (PK) and Pharmacodynamic (PD) Effects of EVP-6308 and the Potential of EVP-6308 to Affect the PK Properties of the Antipsychotic Regimen for schizophrenia.

In Long Beach
Why is this study shown?

This study is directly about Schizophrenia.

SchizophreniaDrugFrom 18 Years to 60 Years
Countries
United States
Sponsor
FORUM Pharmaceuticals Inc
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.